| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
ID: ALA4115089
Max Phase: Preclinical
Molecular Formula: C19H21ClFN3O2
Molecular Weight: 377.85
Molecule Type: Small molecule
Associated Items:
Representations
Canonical SMILES: CC[C@@H](N[C@H](C)CC(N)=O)c1ccc(Cl)c(C(=O)c2ccncc2)c1F
Standard InChI: InChI=1S/C19H21ClFN3O2/c1-3-15(24-11(2)10-16(22)25)13-4-5-14(20)17(18(13)21)19(26)12-6-8-23-9-7-12/h4-9,11,15,24H,3,10H2,1-2H3,(H2,22,25)/t11-,15-/m1/s1
Standard InChI Key: WTEVXJATQCJKAB-IAQYHMDHSA-N
Associated Targets(non-human)
Genome polyprotein 903 Activities
Molecule Features
| Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
| Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
| Chirality: No | Availability: No | Prodrug: No |
Drug Indications
| MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
|---|
Mechanisms of Action
| Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
|---|
Properties
| Molecular Weight: 377.85 | Molecular Weight (Monoisotopic): 377.1306 | AlogP: 3.41 | #Rotatable Bonds: 8 |
| Polar Surface Area: 85.08 | Molecular Species: NEUTRAL | HBA: 4 | HBD: 2 |
| #RO5 Violations: 0 | HBA (Lipinski): 5 | HBD (Lipinski): 3 | #RO5 Violations (Lipinski): 0 |
| CX Acidic pKa: | CX Basic pKa: 8.03 | CX LogP: 2.78 | CX LogD: 2.07 |
| Aromatic Rings: 2 | Heavy Atoms: 26 | QED Weighted: 0.69 | Np Likeness Score: -0.89 |
References
| 1. (2015) Pharmaceutical compounds, |
Source
Source(1):